Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 35, pseudogene (RNU6-35P) is a non-coding RNA pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a critical component of the spliceosome, essential for nuclear pre-mRNA splicing; however, pseudogenes such as RNU6-35P are non-functional copies that do not produce active RNA molecules or protein products[1][3][4]. These pseudogenes are typically the result of retrotransposition or gene duplication events and are scattered throughout the genome. RNU6-35P itself lacks known biological function, is not considered a molecular target for drugs, and is not implicated as a biomarker or therapeutic target for human disease. The high number and diversity of U6 pseudogenes, including RNU6-35P, reflects ongoing retrotransposon activity in the genome, but their presence serves mainly as markers of genomic evolution and retrotransposition rather than as functional or druggable biological entities[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 35, pseudogene (RNU6-35P).